Back to
Independent Review Committee
Gavi has established an Independent Review Committee for the review of new proposals

Gavi has established an Independent Review Committee for the review of new proposals
Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:
The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.
Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.
The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.
This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:
It also ensures that each new application for support complies with the eligibility criteria, established according to the Gavi guidelines for new proposals of support.
Round opening (on the portal) |
Deadline for submission |
IRC meeting |
---|---|---|
~2mths prior |
19 January 2021 |
8–19 March 2021 |
~2mths prior |
4 May 2021 |
28 June–9 July 2021 |
~2mths prior |
15 September 2021 |
8–19 Nov 2021 |
Members of the Independent Review Committee consist of specialists from a broad range of expertise.
IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.
The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:
The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.
Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.
|
Name |
Areas of expertise |
---|---|---|
1 | Saidou Pathé Barry | HSS, national health strategies, policy dialogue in the health sector, M&E, primary health care |
2 | Blaise Bikandou | HSS, policy development, vaccine preventable diseases, epidemiology, health programme management and administration |
3 | Francois Boilloit | Disease control, health system development and reform, health financing, development assistance for health |
4 | Brent Burkholder | Epidemiology, vaccine programmes and disease control, outbreak investigations |
5 | Diego Buriot | Public health interventions, communicable diseases, fragile and crisis settings |
6 | Pierre Bwale | Health care delivery, campaigns, emergencies, programmes for hard-to-reach communities |
7 | Lisa Cairns | Immunisation policy, epidemiology, M&R control, national immunisation programme reviews |
8 | Aleksandra Caric | Immunisation, vaccine safety and regulation, programme management and administration |
9 | Dah Cheikh | Organization and management of vaccination programmes, HSS, vaccine campaigns, trainings |
10 | Sadia Chowdhury | Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes |
11 | Natasha Crowcroft | Epidemiology, HSS, HPV, measles, outbreak control, training and capacity building |
12 | Celestino Costa | Cold chain, immunisation, HSS, emergency responses, primary health care |
13 | John Crump | Infectious diseases, epidemiology, outbreak responses, typhoid |
14 | Henrique D’Alva | Cold chain, EPI logistics |
15 | Kevin De Cock | Global public health, HIV, emergency & outbreak response, HSS |
16 | Modibo Dicko | Supply chain management, introducing innovative technologies, management systems and practices in health supply systems |
17 | Rene Dubbeldam | National health policies, essential medicines strategies, child health programmes, community health, epidemiology |
18 | Peter Fonkwo | Health programme design and management, routine &mass campaigns vaccination, HSS, EPI M&E |
19 | Djordie Gikic | HSS, proposal development, immunisation systems evaluation, service delivery, health policies |
20 | Melita Gordon | Gastroenterology, disease surveillance, typhoid, vaccine trials |
21 | John Grundy | Health policy, campaign delivery, HSS, programme evaluation |
22 | Bradley Hersh | Health policy, immunisation, outbreaks, campaigns, measles control |
23 | Natasha Howard | Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background |
24 | Hector Izurieta | Immunisation campaign management, public health, measles control, epidemiology, policy making |
25 | Clifford Kamara | Health development, immunisation services, recovery programme, management and evaluation of health programmes |
26 | Jean Rostand Kamga | Financial & budget analysis, management and governance, audits, financial investigations |
27 | Toagoe Karzon | Project funding, financial reporting and budget control, conducting audits |
28 | Tcha Landry Kaucley | Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management |
29 | Wassim Khrouf | Financial & budget analysis, audits, project assessment |
30 | Vladimir Lazarevik | Healthcare system transformation, health financing design, health policy development |
31 | Stefano Lazzari | Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management |
32 | Dafrossa Lyimo | Immunisation campaign management, public health, health systems management, health policies, disease control |
33 | Osman Mansoor | Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics |
34 | Viviana Mangiaterra | Child health, epidemiology, HSS, immunisation programmes |
35 | Florian Marks | Public health, vaccinology and policy making, outbreak responses, campaign evaluations |
36 | Tawanda Marufu | Fragile settings, HSS, epidemiology, health policy, HPV, Typhoid, measles |
37 | Scott McKeown | Epidemiology, information systems, health service delivery, immunization incl. campaigns, cold chain maintenance |
38 | Mark Miller | Epidemiology, vaccine research, public health, outbreak investigations, disease control |
39 | Kondwani Msampha | Financial & budget analysis, HSS, global health and integrated service delivery |
40 | Benjamin Nkowane | Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health |
41 | Mathieu Noirhomme | Public health, HSS, health policy dialogue, health financing, design thinking & service design, universal health coverage |
42 | Peter Nsubuga | Epidemiology, measles control, cold chain, HSS |
43 | Cornelius Oepen | HSS, urban health, health security, mass vaccination/campaigns, evaluation of research programmes |
44 | Jean Marc Olive | Immunisation programmes, emergency strategies & disaster relief, measles elimination |
45 | Virgil Onama | Project design, M&E, results-based management, health financing & policy, fragile settings |
46 | Michael Park | Programme management and evaluation, primary care, health systems and public health |
47 | Elisabeth Paul | Health systems and policies, health financing, universal health coverage, performance-based financing, aid effectiveness |
48 | Ian Pett | Health care, cold chain, HSS, outbreak response, emergencies |
49 | Arthur Reingold | Epidemiology, measles control, vaccination delivery, strengthening health infrastructure |
50 | Cheikh Mohamed Hafis Seck | Financial & budget analysis, financial management of donor-funded programs, audit, grant agreements |
51 | Jim Setzer | Health information systems, HSS, disease surveillance, programme and policy planning, M&E, strategic planning |
52 | Craig Shapiro | Management of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities |
53 | Simon (Sam) Sternin | Global health generalist, HSS, disaster management, coverage and equity, CSOs |
54 | Abdelmajid Tibouti | Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation |
55 | Vivien Tsu | Epidemiology, new public health interventions, women's reproductive health, HPV, JE |
56 | Margaret Watkins | Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations |
57 | Karen Wilkins | Immunisation campaign management, proposals development, monitoring and evaluation, DQ assessments |
58 | Aregai Woldegebriel | Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation |